Arlington Trust’s Bristol-Myers Squibb BMY Stock Holding History

Arlington Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.1K	Buy	+610	New	+$35K	﹤0.01%	310
2025 Q2	–	Sell	-274	Closed	-$16.7K	–	707
2025 Q1	$16.7K	Sell	274 -117	-30%	-$6.82K	﹤0.01%	474
2024 Q4	$22.1K	Buy	391 +117	+43%	+$6.54K	﹤0.01%	417
2024 Q3	$14.2K	Sell	274 -1,582	-85%	-$74.2K	﹤0.01%	427
2024 Q2	$77.1K	Buy	1,856 +900	+94%	+$40.3K	0.02%	285
2024 Q1	$51.8K	Sell	956 -100	-9%	-$5.09K	0.01%	282
2023 Q4	$54.2K	Buy	+1,056	New	+$55.4K	0.02%	279

Other funds holding BMY

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return